Waiting for a better opportunities..."Merck" has a market cap of $272.Billion US.
"Merck" has Keytruda,19%CR at 12 months, and a ton of side effects, including death.
"Royalty Pharma" has a market cap of $16 Billion US.
"Royalty Pharma" has Adstiladrin, 24%CR at 12 months, no side effects but a very big immunocompromised restriction.
Top Pharma company...
Eli Lilly & Co Market Cap $426 Billion US.
Johnson & Johnson " $415 Billion US.
Novo Nordisk " $358 Billion US.
With such a big market cap, why is it that these big pharma didn't grab Adstiladrin, could it be that these big pharma are waiting for a better opportunities???